Generate:Biomedicines reveals early Phase 1 GB-0895 data after an ERS poster leak, showing sustained biomarker suppression in asthma, COPD.
Generate:Biomedicines shared Phase 1 data for its respiratory disease drug as part of the European Respiratory Society’s (ERS) annual meeting after posters were prematurely released …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society…
Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The Readout
Endeavor BioMedicines to Present Quantitative Image Analysis from Phase 2a Trial of Taladegib (ENV-101) at European Respiratory…
All of the regular ASCO abstracts dropped Thursday afternoon. Find updates on potential successors for Pfizer’s blockbuster…
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting gave a peek at anticipated datasets from Merck,…
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026
Endeavor BioMedicines to Present Quantitative Image Analysis from Phase 2a Trial of Taladegib (ENV-101) at European Respiratory Society (ERS) Congress 2026
